Ana Vega
@microbepharmd
Followers
580
Following
4K
Media
22
Statuses
265
Infectious diseases pharmacist @JacksonHealth. Passionate about antimicrobial stewardship, health outcomes research, & women in science. Views my own.
Miami, FL
Joined January 2017
Someone created a waiting lounge for our office and I’ve never received a nicer compliment
0
0
1
Had a challenging/rewarding week at work that reminded me why I became an ID pharmacist 🥲
0
0
2
What do we think about the resistant mechanisms of this baddie?
5
4
22
🆕️⚡️⚡️#IJAA @MucorMcCrinkis @ClaeysKcclaeys @liliabbo @microbepharmd Impact of a Real-Time Diagnostic and Antimicrobial Stewardship Workflow on Time-to-Appropriate Therapy for Infections Caused by Multidrug-Resistant Gram-negative Organisms #IDTwitter
https://t.co/IqeBGmy0yy
0
19
39
XDR ACB CNS infection. Any ACB experts out there that can send a Hail Mary recommendation?
0
1
1
We are trying to discourage its use in this kind of scenarios as it could be more common then R/R CMV infections. Let’s wait for the 302 study results evaluating MBV for PET before we can move in this direction. @KottonNelson @EmilyBlumbergMD @RazonableMD @GenPapaMD
Questions for #IDtwitter Is anyone using #maribavir for CMV treatment without resistance when there is leukopenia from valganciclovir? What are the pros and cons to using maribavir in this setting? @KottonNelson @RazonableMD @EmilyBlumbergMD @ChemalyRoy @alan_koff @camwolfe
0
5
17
Me on zoom rounds when the consult order says “osteomyelitis, s/p I+D but no sample sent”
0
0
6
I don’t know who needs to hear this but, there’s a >90% chance that your patient with COVID-19 pneumonia does not need antibiotics.
5
6
98
If every antibiotic prescription required an Informed Consent and Initial Intake Forms then we might fix overprescribing, AMR and C diff 🙄😓 #JustSayin
#IDTwitter
1
5
19
We love a stoplight table! Check out this great summary made by @moore_wjustin of PsA resistance 🦠 to beta-lactams from the recent #Breakpoints discussion with @erinmccreary, @MaggieMonogue, and @aoliverp73. Then listen to the episode for all the details: https://t.co/ez0n3ae0fR
7
187
505
SOT recipients at risk of re-infection despite prior infection (and proof of immune response). More work needed to protect these vulnerable patients. @NatoriYoichiro @FrattaroliMd @FernandezAnmary @liliabbo @JacksonHealth @AST_IDCOP
In the current issue: Colleagues @umiamimedicine describe reinfection with SARS‐CoV‐2 in SOT recipients. Results suggest those SOT recipients infected by virus, even those with an initially reactive IgG or cellular response, remain at risk for reinfection
2
5
24
Meet the #TxID family at @JacksonHealth @UMiamiHealth with the OG @drmichelemorris. What’s your #TxID family like? @AST_IDCOP @IDSAInfo @TxID_Fellows @TransplantIDNet
3
3
37
🆕⚡⚡Cohort @JAMASurgery In addition to guideline recommendations that sepsis care should include, source control within 6h of sepsis onset was associated with a reduced risk-adjusted odds of 90-day mortality #IDTwitter #MedEd #TwitteRx
https://t.co/4QkKEKX0lj
jamanetwork.com
This cohort study evaluates data from a 14-hospital integrated health care system to determine the association between time to source control and patient outcomes in community-acquired sepsis.
3
52
115
Today, the Supreme Court not only reversed nearly 50 years of precedent, it relegated the most intensely personal decision someone can make to the whims of politicians and ideologues—attacking the essential freedoms of millions of Americans.
34K
168K
741K